BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 11044823)

  • 1. Delayed-type skin reaction to the heparin-alternative danaparoid.
    Szolar-Platzer C; Aberer W; Kränke B
    J Am Acad Dermatol; 2000 Nov; 43(5 Pt 2):920-2. PubMed ID: 11044823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Eczematous plaques related to unfractionated and low-molecular-weight heparins: cross-reaction with danaparoid but not with desirudin.
    Martin L; Machet L; Gironet N; Pouplard C; Gruel Y; Vaillant L
    Contact Dermatitis; 2000 May; 42(5):295-6. PubMed ID: 10789857
    [No Abstract]   [Full Text] [Related]  

  • 3. [Delayed hypersensitivity to heparins and heparinoids].
    Nicolie B; Bonneau JC; Le Sellin J; Gay G; Leclere JM; Drouet M
    Allerg Immunol (Paris); 2002 Feb; 34(2):47-50. PubMed ID: 11933754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delayed cutaneous reaction to unfractionated heparin, low molecular weight heparin and danaparoid.
    Sivakumaran M; Ghosh K; Munks R; Gelsthorpe K; Tan L; Wood JK
    Br J Haematol; 1994 Apr; 86(4):893-4. PubMed ID: 7802799
    [No Abstract]   [Full Text] [Related]  

  • 5. Tolerance of fondaparinux in a patient allergic to heparins and other glycosaminoglycans.
    Ludwig RJ; Beier C; Lindhoff-Last E; Kaufmann R; Boehncke WH
    Contact Dermatitis; 2003 Sep; 49(3):158-9. PubMed ID: 14678213
    [No Abstract]   [Full Text] [Related]  

  • 6. [Use of low molecular weight heparins by dermatologists].
    Maakaroun A; Gruel Y
    Ann Dermatol Venereol; 2003 Apr; 130(4):473-8. PubMed ID: 12843865
    [No Abstract]   [Full Text] [Related]  

  • 7. Delayed-type hypersensitivity and cross-reactivity to heparins and danaparoid: a prospective study.
    Grassegger A; Fritsch P; Reider N
    Dermatol Surg; 2001 Jan; 27(1):47-52. PubMed ID: 11231243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Delayed intracutaneous test reaction in heparin intolerance].
    Wurpts G; Merk HF
    Hautarzt; 2007 May; 58(5):394-6. PubMed ID: 17450341
    [No Abstract]   [Full Text] [Related]  

  • 9. Association of heparin-induced skin lesions, intracutaneous tests, and heparin-induced IgG.
    Harenberg J; Huhle G; Wang L; Hoffmann U; Bayerl C; Kerowgan M
    Allergy; 1999 May; 54(5):473-7. PubMed ID: 10380778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fatal danaparoid-sodium induced thrombocytopenia and arterial thromboses.
    Tardy B; Tardy-Poncet B; Viallon A; Piot M; Mazet E
    Thromb Haemost; 1998 Sep; 80(3):530. PubMed ID: 9759647
    [No Abstract]   [Full Text] [Related]  

  • 11. Successful use of heparinoids in a pregnancy complicated by allergy to heparin.
    Taylor AA
    BJOG; 2001 Sep; 108(9):1011-2. PubMed ID: 11563455
    [No Abstract]   [Full Text] [Related]  

  • 12. Low-molecular-weight heparins or heparinoids versus standard unfractionated heparin for acute ischemic stroke (Cochrane review).
    Counsell C; Sandercock P
    Stroke; 2002 Jul; 33(7):1925-6. PubMed ID: 12105377
    [No Abstract]   [Full Text] [Related]  

  • 13. Heparin-induced thrombocytopenia: cross-reactivity between standard heparin, low molecular weight heparin, dalteparin (Fragmin) and heparinoid, danaparoid (Orgaran).
    Ramakrishna R; Manoharan A; Kwan YL; Kyle PW
    Br J Haematol; 1995 Nov; 91(3):736-8. PubMed ID: 8555084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Delayed-type hypersensitivity to subcutaneous heparin with tolerance of i.v. administration.
    Liew G; Campbell C; Thursby P
    ANZ J Surg; 2004 Nov; 74(11):1020-1. PubMed ID: 15550103
    [No Abstract]   [Full Text] [Related]  

  • 15. Eczematous plaques related to unfractionated and low-molecular-weight heparin in pregnancy: cross-reaction with danaparoid sodium.
    Blickstein D; Hod M; Bar J
    Blood Coagul Fibrinolysis; 2003 Dec; 14(8):765-8. PubMed ID: 14614358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Thrombopenia increased by heparin and danaparoid].
    Godet G; Bertrand M; Van de Steen E; Boccara G; Koskas F
    Ann Fr Anesth Reanim; 2001 Jan; 20(1):50-3. PubMed ID: 11234580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ardeparin and danaparoid for prevention of deep vein thrombosis.
    Med Lett Drugs Ther; 1997 Oct; 39(1011):94-5. PubMed ID: 9379998
    [No Abstract]   [Full Text] [Related]  

  • 18. A comparative review of the adverse effect profiles of heparins and heparinoids.
    Borris LC; Lassen MR
    Drug Saf; 1995 Jan; 12(1):26-31. PubMed ID: 7537967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tolerance of desirudin in a patient with generalized eczema after intravenous challenge with heparin and a delayed-type skin reaction to high and low molecular weight heparins and heparinoids.
    Schiffner R; Glässl A; Landthaler M; Stolz W
    Contact Dermatitis; 2000 Jan; 42(1):49. PubMed ID: 10644031
    [No Abstract]   [Full Text] [Related]  

  • 20. Management of allergy to heparins in postoperative care: subcutaneous allergy and intravenous tolerance.
    Seitz CS; Brocker EB; Trautmann A
    Dermatol Online J; 2008 Sep; 14(9):4. PubMed ID: 19061586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.